EP2627346
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.10.2011EP published:
23.3.2016EP application number:
11775734.4
EPO information:
European Patent Register
Max expiry date:
13.10.2031
Title:
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS
Timeline
Today
14.10.2011EP application
23.3.2016EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
COMBETTE, Jean-MarcAddress:
Saint-Cergues, FR
Name:
DELOCHE, CatherineAddress:
Genf, CH
Name:
ABADIE, ClaireAddress:
Annecy, FR
Priority
Number:
PCT/EP2011/000307Date:
25.1.2011Country:
WO
Number:
PCT/EP2010/006284Date:
14.10.2010Country:
WO
Classification
Categories:
A61K 38/00, A61K 38/03, A61K 38/04, A61P 27/02